Englewood Lab Statistics
Total Valuation
Englewood Lab has a market cap or net worth of KRW 244.37 billion. The enterprise value is 235.64 billion.
| Market Cap | 244.37B | 
| Enterprise Value | 235.64B | 
Important Dates
The next estimated earnings date is Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 | 
| Ex-Dividend Date | Dec 27, 2024 | 
Share Statistics
Englewood Lab has 19.87 million shares outstanding.
| Current Share Class | 19.87M | 
| Shares Outstanding | 19.87M | 
| Shares Change (YoY) | n/a | 
| Shares Change (QoQ) | n/a | 
| Owned by Insiders (%) | 5.08% | 
| Owned by Institutions (%) | 1.75% | 
| Float | 6.92M | 
Valuation Ratios
The trailing PE ratio is 16.86 and the forward PE ratio is 12.77.
| PE Ratio | 16.86 | 
| Forward PE | 12.77 | 
| PS Ratio | 1.33 | 
| PB Ratio | 1.74 | 
| P/TBV Ratio | 1.76 | 
| P/FCF Ratio | 19.27 | 
| P/OCF Ratio | 14.76 | 
| PEG Ratio | n/a | 
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.49, with an EV/FCF ratio of 18.58.
| EV / Earnings | 16.26 | 
| EV / Sales | 1.28 | 
| EV / EBITDA | 8.49 | 
| EV / EBIT | 10.45 | 
| EV / FCF | 18.58 | 
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.70 | 
| Quick Ratio | 1.90 | 
| Debt / Equity | 0.19 | 
| Debt / EBITDA | 0.94 | 
| Debt / FCF | 2.05 | 
| Interest Coverage | 18.31 | 
Financial Efficiency
Return on equity (ROE) is 10.70% and return on invested capital (ROIC) is 9.06%.
| Return on Equity (ROE) | 10.70% | 
| Return on Assets (ROA) | 7.23% | 
| Return on Invested Capital (ROIC) | 9.06% | 
| Return on Capital Employed (ROCE) | 14.84% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | n/a | 
| Employee Count | n/a | 
| Asset Turnover | 0.94 | 
| Inventory Turnover | 3.41 | 
Taxes
In the past 12 months, Englewood Lab has paid 5.77 billion in taxes.
| Income Tax | 5.77B | 
| Effective Tax Rate | 28.47% | 
Stock Price Statistics
The stock price has increased by +9.34% in the last 52 weeks. The beta is 0.60, so Englewood Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 | 
| 52-Week Price Change | +9.34% | 
| 50-Day Moving Average | 12,941.40 | 
| 200-Day Moving Average | 10,899.55 | 
| Relative Strength Index (RSI) | 42.92 | 
| Average Volume (20 Days) | 152,556 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
In the last 12 months, Englewood Lab had revenue of KRW 183.82 billion and earned 14.49 billion in profits. Earnings per share was 729.37.
| Revenue | 183.82B | 
| Gross Profit | 42.92B | 
| Operating Income | 22.55B | 
| Pretax Income | 20.26B | 
| Net Income | 14.49B | 
| EBITDA | 27.76B | 
| EBIT | 22.55B | 
| Earnings Per Share (EPS) | 729.37 | 
Balance Sheet
The company has 34.79 billion in cash and 26.05 billion in debt, giving a net cash position of 8.73 billion or 439.51 per share.
| Cash & Cash Equivalents | 34.79B | 
| Total Debt | 26.05B | 
| Net Cash | 8.73B | 
| Net Cash Per Share | 439.51 | 
| Equity (Book Value) | 140.48B | 
| Book Value Per Share | 7,070.96 | 
| Working Capital | 102.72B | 
Cash Flow
In the last 12 months, operating cash flow was 16.56 billion and capital expenditures -3.88 billion, giving a free cash flow of 12.68 billion.
| Operating Cash Flow | 16.56B | 
| Capital Expenditures | -3.88B | 
| Free Cash Flow | 12.68B | 
| FCF Per Share | 638.22 | 
Margins
Gross margin is 23.35%, with operating and profit margins of 12.27% and 7.88%.
| Gross Margin | 23.35% | 
| Operating Margin | 12.27% | 
| Pretax Margin | 11.02% | 
| Profit Margin | 7.88% | 
| EBITDA Margin | 15.10% | 
| EBIT Margin | 12.27% | 
| FCF Margin | 6.90% | 
Dividends & Yields
This stock pays an annual dividend of 103.00, which amounts to a dividend yield of 0.81%.
| Dividend Per Share | 103.00 | 
| Dividend Yield | 0.81% | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | 2 | 
| Payout Ratio | 13.85% | 
| Buyback Yield | n/a | 
| Shareholder Yield | 0.81% | 
| Earnings Yield | 5.93% | 
| FCF Yield | 5.19% | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
Englewood Lab has an Altman Z-Score of 4.06 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.06 | 
| Piotroski F-Score | 6 |